Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4457591000168118 | isatuximab 500 mg / 25 mL injection, 25 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4457601000168113 | isatuximab 500 mg/25 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| isatuximab 500 mg/25 mL injection, vial | Is a | isatuximab | true | Inferred relationship | Some | ||
| isatuximab 500 mg/25 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| isatuximab 500 mg/25 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| isatuximab 500 mg/25 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 2004756826 | |
| isatuximab 500 mg/25 mL injection, vial | has Australian BoSS | isatuximab | true | Inferred relationship | Some | 2112032227 | |
| isatuximab 500 mg/25 mL injection, vial | has intended active ingredient | isatuximab | true | Inferred relationship | Some | 2112032227 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sarclisa 500 mg/25 mL injection, 25 mL vial | Is a | True | isatuximab 500 mg/25 mL injection, vial | Inferred relationship | Some | |
| isatuximab 500 mg/25 mL injection, 1 x 25 mL vial | has MPUU | True | isatuximab 500 mg/25 mL injection, vial | Inferred relationship | Some | 1400173827 |
Reference Sets
Medicinal product unit of use reference set
FHIR